EQT X to Acquire Adalvo (B2B Generic Drug Dossiers)
July 18, 2025
EQT X (EQT) has agreed to acquire a majority stake in Adalvo, an asset-light B2B dossier developer that produces market-approval-ready generic drug dossiers for pharmaceutical companies. Existing shareholders, including Aztiq (holding company of Chairman Róbert Wessman), will reinvest part of their holdings and retain minority ownership. The deal is subject to customary approvals and is expected to close in H2 2025.
- Buyers
- EQT X
- Targets
- Adalvo
- Sellers
- Aztiq
- Industry
- Healthcare Services
- Location
- Malta
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
EQT X to Acquire Adevinta's Spanish Online Classifieds Businesses
July 21, 2025
E-Commerce
EQT X has agreed to acquire Adevinta's Spanish operations ("Adevinta Spain"), which include major Spanish online classifieds platforms such as Coches.net, InfoJobs, Milanuncios, Fotocasa, and Habitaclia. The transaction is expected to close in Q1 2026, subject to customary approvals and conditions.
-
ADQ Acquires Acino from Avista Capital and Nordic Capital
September 16, 2021
Pharmaceuticals
Abu Dhabi holding company ADQ has agreed to acquire Acino, a Swiss pharmaceutical company headquartered in Zurich, from private equity owners Avista Capital Partners and Nordic Capital. The transaction supports ADQ's strategy to build a regional pharmaceuticals and healthcare platform, expanding capabilities in manufacturing, commercialization and distribution across emerging markets.
-
Novo Holdings Acquires Ellab from EQT Private Equity
June 21, 2023
Medical Devices
Novo Holdings A/S has agreed to acquire Ellab from EQT Mid Market Europe (EQT Private Equity); the deal was announced in June and subsequently completed following regulatory approvals. Headquartered in Hillerød, Denmark, Ellab is a provider of validation and monitoring hardware, software and services for the biotech and pharmaceutical industries; the Lundbeck Foundation has also agreed to acquire a significant minority stake.
-
TriNetX Acquires Advera Health Analytics
January 21, 2022
Data & Analytics
TriNetX has acquired Advera Health Analytics, the developer of the Evidex pharmacovigilance platform, to integrate Advera’s drug safety software and datasets into its real-world data network. The deal aims to give life sciences clients real-time safety signal detection, validation, and investigation capabilities by combining Evidex with TriNetX’s federated clinical datasets.
-
Aditxt Signs Share Exchange Agreement to Acquire AiPharma Global Holdings
December 28, 2021
Healthcare Services
Aditxt (Nasdaq: ADTX) signed a share exchange agreement to acquire AiPharma Global Holdings LLC (AiPharma Global) in a two-step transaction involving an initial closing and a secondary closing, subject to conditions including regulatory, board, shareholder, and Nasdaq approvals. The deal would give Aditxt 9.5% of AiPharma at the initial closing and the remaining 90.5% at the secondary closing, with cash payments and Aditxt share issuance at each step.
-
EQT (via Otello BidCo AB) Acquires OX2 AB
October 8, 2024
Energy
EQT Infrastructure VI, through acquisition vehicle Otello BidCo AB, completed a recommended public offer to acquire 100% of OX2 AB at SEK 60 per share and now controls 98.81% of the company; OX2 has applied for delisting from Nasdaq Stockholm. EQT says it will support OX2's evolution from a pure developer to an integrated renewables developer and asset owner and provide additional investment to grow the company's pipeline across onshore/offshore wind, solar and storage.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.